
Psychosomatics 41:104-113, April 2000
© 2000 The Academy of Psychosomatic Medicine
Antidepressant Treatment of Fibromyalgia
A Meta-Analysis and Review
Lesley M. Arnold, M.D.,
Paul E. Keck, Jr., M.D., and
Jeffrey A. Welge, Ph.D.
Received March 2, 1999; revised July 20, 1999; accepted July 28, 1999. From the Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio; and the Center for Biostatistical Services, University of Cincinnati Medical Center, Cincinnati, Ohio. Address reprint requests to Dr. Arnold, Department of Psychiatry, University of Cincinnati College of Medicine, P.O. Box 670559, 231 Bethesda Avenue, Cincinnati, OH 452670559; e-mail: arnoldlm{at}email.uc.edu
Fibromyalgia is a common musculoskeletal pain disorder associated with mood disorders. Antidepressants, particularly tricyclics, are commonly recommended treatments. Randomized, controlled trials of antidepressants for treatment of fibromyalgia were reviewed by methodology, results, and potential predictors of response. Twenty-one controlled trials, 16 involving tricyclic agents, were identified; 9 of these 16 studies were suitable for meta-analysis. Effect sizes were calculated for measurements of physician and patient overall assessment, pain, stiffness, tenderness, fatigue, and sleep quality. Compared with placebo, tricyclic agents were associated with effect sizes that were substantially larger than zero for all measurements. The largest improvement was associated with measures of sleep quality; the most modest improvement was found in measures of stiffness and tenderness. Further studies are needed utilizing randomized, double-blind, placebo-controlled, parallel designs with antidepressants administered at therapeutic dose ranges, using standardized criteria for fibromyalgia and systematically assessed for co-occurring psychiatric illness.
Key Words: Antidepressants Fibromyalgia
This article has been cited by other articles:

|
 |

|
 |
 
S. Perrot, R.-M. Javier, M. Marty, C. Le Jeunne, F. Laroche, and the CEDR (Cercle d'Etude de la Douleur en Rhumatol
Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies
Rheumatology,
August 1, 2008;
47(8):
1117 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Rooks, S. Gautam, M. Romeling, M. L. Cross, D. Stratigakis, B. Evans, D. L. Goldenberg, M. D. Iversen, and J. N. Katz
Group Exercise, Education, and Combination Self-management in Women With Fibromyalgia: A Randomized Trial
Arch Intern Med,
November 12, 2007;
167(20):
2192 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Da Costa, M. Abrahamowicz, I. Lowensteyn, S. Bernatsky, M. Dritsa, M.-A. Fitzcharles, and P. L. Dobkin
A randomized clinical trial of an individualized home-based exercise programme for women with fibromyalgia
Rheumatology,
November 1, 2005;
44(11):
1422 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Krell, A. F. Leuchter, I. A. Cook, and M. Abrams
Evaluation of Reboxetine, a Noradrenergic Antidepressant, for the Treatment of Fibromyalgia and Chronic Low Back Pain
Psychosomatics,
October 1, 2005;
46(5):
379 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Goldenberg, C. Burckhardt, and L. Crofford
Management of Fibromyalgia Syndrome
JAMA,
November 17, 2004;
292(19):
2388 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sewitch, P. L. Dobkin, S. Bernatsky, M. Baron, M. Starr, M. Cohen, and M.-A. Fitzcharles
Medication non-adherence in women with fibromyalgia
Rheumatology,
May 1, 2004;
43(5):
648 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sayar, G. Aksu, I. Ak, and M. Tosun
Venlafaxine Treatment of Fibromyalgia
Ann. Pharmacother.,
November 1, 2003;
37(11):
1561 - 1565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Ghafoor
Treatment of Chronic Pain
Journal of Pharmacy Practice,
August 1, 2003;
16(4):
249 - 260.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Afari and D. Buchwald
Chronic Fatigue Syndrome: A Review
Am J Psychiatry,
February 1, 2003;
160(2):
221 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wessely
Women experienced chronic fatigue syndrome and fibromyalgia as stigmatising
Evid. Based Ment. Health,
November 1, 2002;
5(4):
127 - 127.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Smith, D. M. Clarke, D. Handrinos, A. Dunsis, and D. P. McKenzie
Consultation-Liaison Psychiatrists' Management of Somatoform Disorders
Psychosomatics,
December 1, 2000;
41(6):
481 - 489.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Antidepressants Ease Fibromyalgia Symptoms
Journal Watch Women's Health,
May 1, 2000;
2000(501):
11 - 11.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|